Suchbegriff wählen

academia

The fourth ORBIS School enhancing international collaboration on pharmaceutical innovations was held in Prague

Between 7th and 9th September, the fourth ORBIS School was held in Prague. The event was co-hosted by Zentiva in close collaboration with the German company Physiolution and the University of Chemistry and Technology in Prague. Many various lectures and workshops were held during these three days and the participants had a great opportunity to share their experiences and knowledge based on their own research. Part of the program was a visit to Zentivas R&D department in its Prague site. ORBIS (Open Research

68th Bilderberg Meeting to take place 2 – 5 June 2022 in Washington, D.C., USA

Washington, D.C., USA (ots) - The 68th Bilderberg Meeting will take place from 2 - 5 June 2022 in Washington, D.C., USA. About 120 participants from 21 countries have confirmed their attendance. As ever, a diverse group of political leaders and experts from industry, finance, academia, labour and the media has been invited. The list of participants is available on bilderbergmeetings.org. The key topics for discussion this year are: 1. Geopolitical Realignments 2. NATO Challenges 3. China 4. Indo-Pacific Realignment

‚Davos of digital wellbeing‘ gets underway with ambition to drive greater understanding of digital harms

Dhahran, Saudi Arabia (ots/PRNewswire) - * The inaugural Sync Digital Wellbeing Summit (29-30 March) will raise awareness of the hidden realities of our relationship with digital services * Leadership from IBM, UNESCO and Childnet amongst those speaking at sessions across the two-day Summit * Full Summit agenda can be viewed here * Media wanting to virtually attend any of the sessions can register via this link 1. https://sync.ithra.com/sync-summit 2. https://dws.registration-system.fr/virtual/request-invitation

Abcam the most awarded company at 2022 industry awards

Cambridge, England (ots/PRNewswire) - CAMBRIDGE, England, March 25, 2022 Abcam (AIM:ABC); (NASDAQ:ABCM), today announced that it has received six recognitions from CiteAb at their annual industry awards, the highest of any participant evaluated this year. This record number of acknowledgments follows a year of substantial investment for Abcam to enable life sciences researchers from academia and industry to advance discoveries and deliver faster breakthroughs. First and foremost, Abcam was recognized for its

Abcam the most awarded company at 2022 industry awards

Cambridge, England (ots/PRNewswire) - CAMBRIDGE, England, March 25, 2022 Abcam (AIM:ABC); (NASDAQ:ABCM), today announced that it has received six recognitions from CiteAb at their annual industry awards, the highest of any participant evaluated this year. This record number of acknowledgments follows a year of substantial investment for Abcam to enable life sciences researchers from academia and industry to advance discoveries and deliver faster breakthroughs. First and foremost, Abcam was recognized for its

ALDER HEY AND NEEDLESMART PARTNERSHIP AIMS TO REDUCE 100,000 NEEDLESTICK INJURIES TO NHS HEALTHCARE WORKERS

Liverpool, United Kingdom (OTS) - --News Direct-- BRITISH SMART MEDTECH COMPANY INVENTS WORLD’S FIRST END-TO-END SAFE NEEDLE DESTRUCTION TECHNOLOGY TECH AIMS TO REDUCE 3 MILLION GLOBAL NEEDLESTICK INJURIES In a recent survey*, it was reported that a staggering 94 per cent of practising surgeons in the UK have either been personally affected by a needlestick injury (NSI) or have seen a colleague experience one. The Royal College Of Nursing also reported last year that the pressures of the pandemic and lack of

Whole genome sequencing improves diagnosis of rare diseases and shortens diagnostic journeys for patients, according to world first study

London (ots/PRNewswire) - NB: SCIENCE MEDIA BRIEFING TAKING PLACE 14:00 GMT 9TH NOVEMBER 2021 - whole genome sequencing proved to be a better way to diagnose rare diseases than usual genomic testing methods - whole genome sequencing led to new rare disease diagnoses for NHS patients in some cases ending decades-long diagnostic odysseys - study represents significant step towards the goal of precision medicine - a transition that will have huge impact across the NHS and globally A world-first scientific study,

Call for climate protection for smallholders that produce one third of global food

Glasgow, Scotland (ots/PRNewswire) - UK boosts commitment to curtail agricultural emissions and reduce climate-induced loss and damage CGIAR urged global leaders today to ensure the 500 million smallholder farmers responsible for up to a third of global food production can adapt to climate change-induced loss and damage. Innovations are needed that can both reduce the contribution of global agriculture to climate change, and adapt to its increasingly evident consequences while also supporting livelihoods, nutrition and

Zentiva Advances Pharmaceutical Research Through ORBIS Project

Prague (ots/PRNewswire) - One of the missions that Zentiva has consistently pursued is to connect Academia and the Pharmaceutical Industry to accelerate drug development innovation and meet the unmet needs of the patients. Our company is pleased to resume the scientific exchange program as part of the ORBIS project, which was created within the largest EU grant programs HORIZON 2020, to connect European and American universities with Industrial partners at the scientific level. Thanks to the experience gained in the

Abcam completes $340m strategic acquisition and expands kit capacity and capability

Cambridge, England (ots/PRNewswire) - - Completing $340m strategic acquisition of BioVision - Expanding facilities in Eugene, further growing kits and assays portfolio - Supporting the growing demand of the sector and accelerating execution of strategic plan Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools, today announces the successful completion of its acquisition of BioVision and the expansion of its immunoassay capacity in Eugene, OR. Across the life sciences sector, the